-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Total costs of sales and operating expenses for the period.
-
Summary
-
Royalty Pharma plc quarterly/annual Costs and Expenses history and growth rate from Q2 2019 to Q4 2024.
- Royalty Pharma plc Costs and Expenses for the quarter ending December 31, 2024 was $232M.
- Royalty Pharma plc Costs and Expenses for the twelve months ending December 31, 2024 was $971M, a 12.6% increase year-over-year.
- Royalty Pharma plc annual Costs and Expenses for 2024 was $971M, a 12.6% increase from 2023.
- Royalty Pharma plc annual Costs and Expenses for 2023 was $862M, a 55.3% decline from 2022.
- Royalty Pharma plc annual Costs and Expenses for 2022 was $1.93B, a 125% increase from 2021.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Quarterly (USD)
Costs and Expenses, YoY Quarterly Growth (%)